
Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour
Merck has kicked off its 2023 Curiosity Cube tour in Europe and North America. Merck, a leading science and technology company, has kicked off its […]
Merck has kicked off its 2023 Curiosity Cube tour in Europe and North America. Merck, a leading science and technology company, has kicked off its […]
This year’s focus lies on research to support sustainability and the development of next-generation genomic tools in agriculture / Researchers will receive funding and mentorship […]
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Duality Biologics (Suzhou) Co. Ltd. (“DualityBio”), a clinical-stage biotech company focusing on the discovery and development of next generation […]
Bayer establishes Bioethics Council Experts from different academic disciplines to provide broad external perspective and guidance on complex bioethical questions related to emerging life […]
BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) today announced that it has entered into a new share repurchase program (the “Program”), pursuant to which the […]
Bayer expands global clinical program for darolutamide in prostate cancer Phase III study ARASTEP initiated in hormone-sensitive prostate cancer, in patients with high-risk biochemical […]
Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to […]
Cross-section of organ-on-chip biochip cavities with cells representing intestinal model. A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing […]
Partnering with players along the food value chain is key to tackle challenges of food security and climate change / Bayer makes substantial progress in […]
On December 6, 2022, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, took part in the three-day Food Ingredients Europe 2022 (Fi […]
Merck has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”. Merck, a leading science and technology […]
…to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU, “Ryvu”), a clinical-stage company developing […]
RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected […]
• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]
– Randomized first patient in the Phase 2b EU-SolidAct platform for hospitalized COVID-19 patients –– Initiated Phase 1b/2a trial in 1st line NSCLC patients harboring STK11 […]
Copyright © 2023 | WordPress Theme by MH Themes